Drug-Resistant Bacteria Spread Fast in Bangladesh ICU, Study Warns

Rising Threat of Drug-Resistant Bacteria in Bangladesh’s ICUs

Drug-resistant bacteria are increasingly spreading within intensive care units (ICUs) in Bangladesh, with more than half of ICU patients who were initially free from these dangerous microbes acquiring them during their hospital stay, according to two new studies conducted by icddr,b. The findings highlight a growing public health concern and emphasize the urgent need for improved infection prevention measures.

The research, published in Microbiology Spectrum and Antimicrobial Resistance & Infection Control, analyzed data from 373 critically ill adult patients admitted to the ICU between July 2023 and February 2024, as well as 363 neonates in the neonatal ICU (NICU) between December 2023 and September 2024 at a tertiary care government hospital in Dhaka.

Dr Gazi Md. Salahuddin Mamun, Assistant Scientist at icddr,b and lead author of one of the studies, explained that the team followed ICU patients throughout their stay and used laboratory testing and whole-genome sequencing to track how resistant bacteria spread within the hospital. This approach helped identify links between bacteria carried by patients and those causing deadly infections.

The study, funded by the US Centers for Disease Control and Prevention (CDC), focused on difficult-to-treat Gram-negative bacteria, which are resistant to many commonly used antibiotics. These bacteria can cause serious infections such as pneumonia, bloodstream infections, urinary tract infections, and wound infections, especially among critically ill patients.

An earlier study by icddr,b found widespread colonization with drug-resistant bacteria in hospitals and communities, including among newborns. The current studies add new evidence on how these bacteria spread within ICUs and how improved infection prevention can reduce infections and deaths.

Researchers examined four major Gram-negative bacteria commonly linked to hospital-acquired infections: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The study found that nearly half of the ICU patients (48.5 percent) were colonized with difficult-to-treat resistant Gram-negative bacteria in their gut. Colonization refers to the presence of bacteria in the body without causing infection, although colonized patients remain at risk of developing disease and transmitting the organisms within healthcare settings.

Importantly, 105 out of 198 patients (53 percent), who were initially free from these resistant bacteria, acquired colonization with them during their ICU stay, suggesting substantial in-hospital transmission.

Among patients who developed culture-confirmed infections with these difficult-to-treat bacteria, mortality was alarmingly high. More than 90 percent of patients with these infections died in ICU. Researchers note that the exceptionally high mortality observed in this study may reflect challenges in resource-constrained critical care settings, including limited treatment options and nosocomial infections in overcrowded ICU environments.

Using whole-genome sequencing, researchers also found evidence that in some patients, the same bacterial strain present in the body during colonization later caused infection, indicating possible progression from silent carriage to life-threatening disease.

Dr Fahmida Chowdhury, Lead of the AMR Research Unit at icddr,b and principal investigator of the study, emphasized the importance of infection prevention. “A hospital should be a place of healing, not a place where patients acquire another potentially life-threatening infection while seeking treatment. In our study, more than half of the patients who were initially free from these difficult-to-treat resistant bacteria acquired them during their ICU stay, which is deeply concerning. Strengthening infection prevention and control practices, hospital hygiene, and responsible antibiotic use is essential to better protect critically ill patients.”

While the ICU study highlights the scale of the challenge posed by difficult-to-treat drug-resistant bacteria in Bangladesh’s hospitals, a second study from the same research team demonstrates that hospitals can significantly reduce infections through stronger infection prevention and control practices.

Published in Antimicrobial Resistance & Infection Control, the study evaluated a targeted infection prevention and control program in a neonatal intensive care unit (NICU) in Dhaka. Researchers provided baseline and monthly training to healthcare workers and cleaning staff on hand hygiene, environmental cleaning, waste management, and infection prevention practices, while also monitoring compliance, bloodstream infections, mortality, and colonization with carbapenem-resistant organisms.

After seven months of continued intervention, bloodstream infections fell from 28 to 4 per 100 admissions, representing an 86 percent reduction, while mortality decreased from 26 to 4 deaths per 100 admissions. This suggests that even in settings where resistant bacteria are present, stronger infection prevention and control measures can prevent these organisms from causing life-threatening infections.

Dr Tahmeed Ahmed, Executive Director of icddr,b, said, “These studies reveal a troubling reality: patients are acquiring difficult-to-treat drug-resistant bacteria while receiving care in our hospitals, and the consequences can be devastating. At the same time, they show that strengthening basic infection prevention and control measures can dramatically reduce infections and deaths. Hospital authorities and policymakers must treat infection prevention, hospital hygiene, surveillance, and responsible antibiotic use as core patient safety priorities if we are to protect patients and combat antimicrobial resistance.”

Key Findings and Recommendations

The two studies provide a clear message for healthcare facilities in Bangladesh and other resource-constrained settings. While drug-resistant bacteria are spreading within hospitals and contributing to poor patient outcomes, healthcare facilities are not powerless. Strengthening infection prevention and control measures—including hand hygiene, environmental cleaning, antimicrobial stewardship, surveillance, and safe patient care practices—can significantly reduce infections.

The findings reinforce that investing in infection prevention and control is one of the most effective strategies available for combating antimicrobial resistance and protecting vulnerable patients.